R ecent evidence suggests that graft rejection is mediated in part by the recirculating pool of peripheral blood lymphocytes and follows fundamentally the same rules that govern foreign peptide recognition, ie, foreign peptide presented in the context of endogenously derived (self)-MHC molecules. In the case of allorecognition, however, a self-peptide is presented by the foreign MHC molecule. This combination mimics a foreign peptide presented by self-MHC and is recognized by a large proportion of mature T cells. 1, 2 Although rejection is mediated by peripheral lymphocytes, lymphoid markers corresponding to histologically diagnosed rejection have been difficult to demonstrate. During an immune-mediated or other inflammatory response, memory T cells are programmed to migrate into the inflamed tissues, and naive T cells are programmed to migrate into lymph nodes.3 Therefore, a change in the number or proportion of T-cell subsets in the peripheral blood would be expected coincident with rejection. Indeed, some reports have documented changes in the number of peripheral blood lymphocytes during rejection,4 whereas other reports have not. 5 However, most approaches to cytoimmunological monitoring of peripheral lymphoid populations during rejection have focused principally on the two major T-cell subsets, CD4 and CD8.6 Within these broad categories, only large alterations in cell number would be detectable. Therefore, these previous studies may suffer from lack of sensitivity. Recently, it has been recognized that T cells can be further subclassified by the specific T-cell receptor (TCR) that is expressed.
The human TCR is a heterodimer composed of a and 13 polypeptide chains. The a chain is made up of variable (V), joining (J), and constant (C) regions; the 1 chain is made up of V, J, and C regions, with an additional sequence (the diversity, or D, region) located between the V and J regions.7 Analysis of a and /8 chain genes has allowed the assignment of all human TCR into families and subfamilies based on similarities in the a and P3 chain gene sequences, primarily in the V region gene segment.8 9 Antibodies have been produced allowing serological identification of a large proportion of these families. [10] [11] [12] [13] [14] [15] In the present study, we used a panel of monoclonal antibodies to TCR /8 chain V region epitopes to quantitate T-cell subsets in the peripheral blood of recipient patients after transplantation. Because 
Cultures for Cytomegalovirus
Cultures for cytomegalovirus (CMV) identification were done by the shell vial culture technique without centrifugation. MRC-5 human embryonic lung cells were obtained routinely (Viromed) and passed serially for approximately 8 to 10 passages. Cells were split two times a week (at confluency) and maintained in minimal essential medium with nonessential amino acids, 10 ,g/mL gentamycin, 50 ,ug/mL streptomycin, 50 U/mL penicillin, 4 ,ug/mL amphotericin B, 15 mmol/L HEPES, 9.5 mmol/L sodium bicarbonate, and 2% fetal calf serum.
For isolation of CMV, specimens were diluted 1:1 with tissue culture medium, and 0.3 mL was placed into a shell vial containing a coverslip with adherent, freshly cultured (24 to 72 hours) MRC-5 cells. The total volume was adjusted to 2.0 mL with medium, and cultures were incubated at 37°C in 5% CO2.
Cultures were stained at 24 and 48 hours for CMV immediateearly and early antigens using an indirect monoclonal antibody mixture with an Evans blue counterstain (Siva). Characteristic nuclear staining was considered positive.
Correlation Between Abnormal Changes in TCR Expression and Clinical Events After Transplantation
An attempt was made to determine whether abnormal test results correlate with the occurrence of clinically important events. The events studied were acute cellular rejection, vascular rejection, and increased corticosteroid immunosuppressive therapy. The data for all patients were pooled, and 
Results

Comparison of Changes in TCR Expression Over Time Between Transplant Recipients and Controls
Changes in the number of Vp-expressing T-cell subsets were determined for cardiac allograft recipients in the early posttransplantation period and for healthy subjects. Five healthy volunteers were followed for a period of 1 month with blood specimens obtained weekly and subsets quantified. Serial changes in V,8 expression were determined by comparing the number of positive cells at 7-day intervals. A total of 120 ratios (using the panel of six monoclonal antibodies) were calculated for the healthy controls. These ratios are given in Fig 1. Mean and median ratios were 1.03 and 1.0, respectively. A weekly ratio of 1.0 indicates no detectable change in V, expression. Thus, for controls, essentially no quantitative changes occurred among these T-cell subsets during the study period.
The entire range of calculated ratios for the healthy controls was 0.4 to 1.8. The values 0.5 and 2.0 (which correspond to a twofold decrease or twofold increase in cell count, respectively) contained 119 of the 120 calculated ratios (99.2%) for controls and were chosen to be the lower and upper limits of the normal range. A single control value (0.4) fell outside of these limits.
Serial changes in the number of Vfl-expressing T-cell subsets were determined for transplant recipients. These are also given in Fig 1. In total, 246 ratios were calculated; the mean was 1.3 and the median was 1.0, with a range of 0.03 to 10. Although the entire sample of patient subset ratios tended to distribute centrally around 1.0, there was much more variability for the transplant recipients than for the healthy controls. The ratio of the variance between controls and transplant recipients (F test) indicated a significant difference between these populations (F= 19.5, P<.001).
For transplant recipients, 57 of the 240 calculated subset ratios (23.8%) fell outside of the defined normal limits (27 were above and 32 were below the control limits) compared with 1 of 120 (0.8%) for the controls (P<.004, x2).
Correlation Between Abnormal Changes in TCR Expression and Clinical Events After Transplantation
An association between abnormal T-cell subset ratios among transplant recipients and clinical events in the posttransplantation period was examined. The events studied were acute cellular rejection, vascular rejection, and high-dose corticosteroid immunosuppressive therapy. A correlation between test results and infection was also attempted. Patient 4 had a diagnosed infection (CMV ischemic colitis) approximately 57 days after transplantation. This patient was culture positive for CMV for a period of 17 days, during which time abnormal T-cell changes were observed for four of the six subsets examined. A second recipient (patient 5) was culture positive (throat) for CMV 20 days after transplantation; abnormal T-cell subset ratios were seen subsequent to this infection. These limited observations suggest that there may be a relation between CMV infection and perturbations in T-cell subsets (although confirmation will be required). Because of a suspected relation between CMV infection and alterations in T-cell subsets, the abnormal test results obtained for these patients during the period of virus shedding were not included in this data analysis.
The temporal distributions of normal and abnormal serial subset ratios are given in Fig 2A through 2C for the clinical events of interest. As shown, there were no differences between normal and abnormal T-cell subset ratios relative to either vascular rejection or the initiation of high-dose prednisone immunosuppression ( Fig  2B and 2C ). However, a significant difference (P<.005) between the temporal distributions of normal and abnormal T-cell ratios was seen with respect to the occurrence of biopsy-confirmed cellular rejection (Fig  2A) . The abnormal T-cell subset ratios were found to occur a mean (+SD) of 7.7+6.2 days from a biopsy positive for cellular rejection (median, 5 days; range, 0 to 28 days). In contrast, normal test results occurred a mean of 14.4±10.9 days from a biopsy positive for cellular rejection (median, 11 days; range, 0 to 44 days). This observation suggests that abnormal changes in T-cell subset numbers coincide with cellular rejection.
As a further test for correlation between abnormal subset ratios and clinical events, the frequency of occur- rence of abnormal subset ratios was plotted as a function of time to the nearest event in question. These plots were analyzed by linear regression and are presented in Fig 3A through 3C . The frequency of abnormal subset ratios was highest at times surrounding a biopsy positive for cellular rejection (31% of the total number of abnormal ratios occurred within 3 days of a positive biopsy) and decreased proportionally thereafter as time from a positive biopsy increased (Fig 3A) . A highly significant correlation (P<.001, R=.91) between the occurrence of abnormal subset ratios and biopsies positive for cellular rejection was found by linear regression analysis. In contrast, no correlation was found between abnormal subset fluctuations and either biopsy-diagnosed vascular rejection or high-dose prednisone administration. Approximately 24% of abnormal subset ratios were not associated with vascular rejection (>60 days from the nearest positive biopsy), and 32% could not be associated (>60 days) with high-dose prednisone. These results are shown in Fig 2B and 2C but were not included in the regression analyses. Regression analysis was also performed on normal T-cell subset ratios (data not shown); no correlation between normal subset ratios and any event was noted (P>.2 in all cases).
Variations of TCR Expression Presented for Individual Transplant Recipients
The serial variations in TCR expression are presented for four of the graft recipients as a function of time after transplantation (Fig 4) . In addition to subset ratios, the results of histological assessments for cellular and vascular rejection, CMV isolations, and steroid pulses are shown. Of the 57 total abnormal T-cell subset ratios, 54 were observed for these four recipients; these recipients also experienced 9 of the 11 total cellular rejection episodes that occurred during the study.
For patient 3, abnormal T-cell subset ratios were observed over a period of 27 days; 6 of 30 calculated ratios (20%) were abnormal between days 14 and 35 after transplantation. During this same period, four normal biopsies were obtained. A biopsy positive for cellular rejection was obtained on day 41 concurrently with 3 of 6 abnormal T-cell subset ratios (50%).
For patient 4, abnormal subset ratios (9 of 18; 50%) occurred over a period of 10 days, 5 days preceding and 5 days following a biopsy positive for both cellular and vascular rejection. Subset ratios and biopsies were normal for 31 days, at which time subset ratios (3 of 6; 50%) became abnormal 3 days before positive cultures for CMV. CMV cultures continued to be positive, and this patient underwent a subtotal colectomy for ischemic necrosis subsequent to cytomegalic inclusion disease. This patient also received three steroid pulses for vasculitis resulting from OKT3 hypersensitivity.
For patient 5, T-cell subset ratios were abnormal on day 30 after transplantation, 10 days after isolation of CMV. Ratios were normal on day 36 with a biopsy negative for cellular rejection but positive for vascular rejection. Between days 55 and 106, 10 of 48 ratios (21%) were abnormal and 4 of 6 biopsies were positive for cellular rejection (2 were positive for vascular rejec- . tion). Subset ratios returned to normal on day 127 with a biopsy negative for cellular rejection but positive for vascular rejection.
For patient 6, biopsies were positive for cellular rejection on days 23 and 30; 14 of 36 subset ratios (39%) were abnormal for a period surrounding these biopsies (days 15 to 37). The remaining abnormal subset ratios (6 of 24; 25%) occurred within a 13-day period surrounding a biopsy positive for both cellular and vascular rejection (10 days preceding and 3 days following). Subset ratios (n= 18) were normal and biopsies (n=3) were negative for cellular rejection (although positive for vascular rejection) for the next 14 days.
The two patients not shown each experienced a biopsy-proved rejection episode in the time intervals during which they were observed (7 and 17 days, respectively). For these recipients, abnormal subset ratios (n=3) were observed concurrently with the positive biopsy. Vf8 Expression by Graft-Infiltrating T Cells Preliminary investigation of Vfl expression among graft-infiltrating lymphocytes was undertaken in an attempt to understand the mechanisms underlying the above observations. In vivo activated lymphocytes were expanded in vitro by treatment with interleukin-2 and analyzed for Vf expression. T lymphocyte cultures were generated from five myocardial specimens obtained by endomyocardial biopsy from three transplant recipients. The V,l distributions for these five cultures (presented as a percentage of the total) are given in the Table. The normal V,8 distributions for blood specimens from healthy donors (n= 15) are also included in the Table. These normal peripheral blood subset distributions were used as control values for analyzing the biopsyderived lymphocyte cultures. The use of peripheral blood as a control was necessitated by the fact that T cells are not recovered from normal myocardium by this method. Therefore, a more appropriate control was unavailable.
For each of the T-cell cultures, at least one subset was increased in its expression beyond the normal range (greater than the control mean±2 SD), and the remaining subsets were generally reduced in number; one subset in each culture was reduced below the established normal range. This pattern is most clearly seen for the culture generated from the biopsy specimen obtained from recipient 1, 25 days after transplantation. For this culture, 84.7% of the cells were of either the V,B5a or V,5b subset; each of the remaining subsets was markedly reduced below its normal level of expression (3.2% to 4.9% of the total). It is of interest that in addition to the overexpressed subset found in each culture of graft-infiltrating cells, for three of the five cultures derived from biopsy tissue, one of the six V, subsets was completely absent. These findings suggest that the entire T-cell compartment did not proliferate in response to the alloantigens expressed on the graft but rather that proliferation occurred among selected clones belonging to unique Vp3-expressing subsets.
These results also indicate that there may be differences in subset expression within the graft at different times. The three cultures originated from serial biopsy specimens obtained from recipient 1 Thus, there are physiological mechanisms that predict that changes should be identifiable in the peripheral blood at times surrounding the onset of acute graft rejection. However, to date there has been limited success in identifying such changes.4,5Failure to identify changes in the entire T-cell population or the CD4 and/or CD8 subsets does not preclude alterations in smaller T-cell subsets. In the present study, it is believed that the ability to identify alterations in cellular content cells identified by each monoclonal antibody; quantitative alterations in these small subsets could be detected, whereas changes in total cell numbers did not occur.
Although a correlation between cellular rejection and perturbation within T-cell subsets was observed, it appears that immune activation of multiple etiologies can result in the kinds of alterations in TCR expression that were observed for transplant recipients. In the present study, for example, alterations in subset ratios corresponded in time to infections with CMV. In a few instances, subset alterations occurred without an apparent cause. These alterations could have been due to mild, undiagnosed rejection or could have resulted from undiagnosed infection with CMV or another agent. The contribution of additional factors affecting T-cell subsets is also possible. We have observed abnormalities in the number of TCR-expressing subsets in two cases of myocarditis (which returned to normal after therapy) and in a case of systemic lupus erythematosus. Thus, it appears that immune activation of multiple etiologies can result in the kinds of alterations in TCR expression observed for transplant recipients undergoing rejection. However, the fact that similar subset alterations did not occur among the volunteers suggests that these initiating factors are not normally encountered by a healthy individual.
An apparent correlation between increased steroid immunosuppression and subset variability was not observed despite the fact that cellular rejection is often treated with a steroid pulse. This probably can be attributed to facts that only 6 of the 11 episodes of cellular rejection associated with subset alterations were treated with a steroid pulse and that episodes of vascular rejection (not associated with subset alterations) were also treated with high-dose prednisone. Thus, there was no association (real or apparent) between abnormal subset variability and increased immunosuppression.
Finally, the recovery of activated lymphocytes from myocardial tissue from several of the grafts provided information about the expression of the T-cell subsets infiltrating the graft. Although limited, these observations do not support the hypothesis that involvement of a single subset occurs in response to a particular HLA mismatched allograft. In each case, more than one subset was recovered by interleukin-2 expansion. However, receptor expression among these graft-derived T cells was different in each case than the receptor distribution observed for the peripheral blood T cells of healthy controls. Thus, the predominance of a few subsets among T cells isolated from the graft suggests that there is a biased T-cell response to the allograft rather than the occurrence of global activation of all subsets. Similar findings of a restricted repertoire of allospecific T cells generated by several responders against a particular HLA class II allele have recently been reported. 23 In the present study, concurrent evaluation of peripheral blood findings and the pattern of receptor expression among graft-derived T cells was not done because paired blood and biopsy specimens were obtained inspecimens from this same patient (n= 11). Further investigation will be required to establish whether there is a relation between receptor subset expression in the peripheral blood and T-cell subsets that infiltrate the graft.
Although much remains to be learned about the physiological mechanisms that govern these observations, it appears that changes in TCR expression in the blood correlate with events that are associated with T-cell activation. This approach holds potential for the noninvasive monitoring of graft stability after transplantation and may provide insights into the physiology of graft rejection with the potential for the development of more specific tailoring of immunosuppressive therapy in individual patients.
